E. Ohman J:or Asset Management 13F: Cuts SYK Stake by $8.8M

E. Ohman J:or Asset Management cut its stake in Stryker Corporation (NYSE:SYK) by 31,981 shares during the period, according to a Form 13F filing submitted to the Securities and Exchange Commission on October 22, 2026. The institutional investor owned 99,490 shares of the medical device maker valued at roughly $27.4 million at the close of the reporting window.

SYK Stryker Corporation

$297.60 ▼ -13.79% year to date

1M 3M YTD

Daily close · Oct 21, 2026

What Changed in E. Ohman J:or Asset Management's Stryker Position

The fund trimmed its exposure to Stryker Corporation by 24.3% in the filing, lowering its share count from 131,471 shares down to 99,490 shares. That reduction left the firm with a smaller position in the healthcare giant, valued at $27,398,551.

Other Institutional Activity in Stryker

Other large funds have also adjusted their positions in the medical technology company recently. Greenleaf Trust reduced its holdings by 709,231 shares, ending with 15,228,545 shares worth about $4.7 billion.

Stryker Corporation Stock Down 0.4%

Shares of Stryker Corporation recently traded around $303.05 on October 22, 2026, down about 0.8% from an event close of $305.64. The stock sits up 1.9% above its 50-day moving average of $297.28 and down 7.0% from its 200-day moving average of $325.90. The company carries a market capitalization of $114.15 billion.

Recent Earnings

Stryker Corporation reported trailing-twelve-month revenue of $25.84 billion alongside trailing earnings of $9.65 per share. The business generated a net profit margin of 14.4% and a return on equity of 16.5%. Investors look ahead to the company's next earnings update scheduled for October 29, 2026.

Dividend

Stryker pays an annual dividend rate of $3.52 per share, yielding 1.18% with a payout ratio of 36.1%.

Insider Buying and Selling at Stryker Corporation

Company insiders have actively adjusted their holdings over recent months. Robert F. Fletcher sold shares worth $1,394,409 on May 28, 2026. Debra King disposed of 826 shares at an average price of $336.30 for a total value of $277,787 on August 18, 2026. Ronda E. Stryker sold 350,000 shares valued at $117,776,128 on August 19, 2026. Dylan Bram Crotty sold 441 shares on August 21, 2026, at an average price of $328.60 for a total of $144,915.

Analysts Set New Price Targets

Wall Street research firms have updated their outlooks on the stock in recent weeks. TD Cowen maintained a hold rating with a $298.00 target on September 22, 2026, moving down from $355.00. Stifel maintained a buy rating on September 30, 2026, adjusting its target from $360.00 to $330.00. Truist Securities maintained a hold rating on October 7, 2026, lowering its target to $310.00 from $340.00. Barclays initiated coverage on October 7, 2026, with an overweight rating and a $375.00 target. BTIG maintained a buy rating on October 12, 2026, adjusting its target to $316.00 from $358.00. Overall, the stock holds a consensus buy rating and a mean price target of $362.62 across 26 analyst opinions.

About Stryker

Stryker Corporation is a medical technology company based in Portage, Michigan. It designs and distributes specialized equipment, surgical tools, neurotechnology systems, and orthopedic implants to healthcare providers globally. Institutional shifts in the stock arrive as the company prepares its upcoming quarterly financial report.

Bottom Line

Investors are monitoring Stryker Corporation ahead of its upcoming earnings report on October 29, 2026. Institutional adjustments and recent insider transactions continue to shape market sentiment for the healthcare provider.